Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study.
Abdel Aziz ShaheenGilaad G KaplanKeith A SharkeyB Cord LethebeMark G SwainPublished in: Hepatology communications (2023)
Although prevalent among viral hepatitis patients, MDD did not affect disease progression or survival in either HBV or HCV cohorts. TCA use was associated with poor decompensated cirrhosis-free survival. Therefore, its use should be further studied among viral hepatitis patients.
Keyphrases
- end stage renal disease
- ejection fraction
- free survival
- newly diagnosed
- chronic kidney disease
- major depressive disorder
- heart failure
- sars cov
- prognostic factors
- depressive symptoms
- hepatitis c virus
- hepatitis b virus
- patient reported outcomes
- human immunodeficiency virus
- bipolar disorder
- liver failure
- atrial fibrillation